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In vitro evaluation of bi-layer silk fibroin 
scaffolds for gastrointestinal tissue 
engineering
Debra Franck1, Yeun Goo Chung1,2, Jeannine Coburn3, David L 
Kaplan3, Carlos R Estrada Jr1,2 and Joshua R Mauney1,2
Abstract
Silk fibroin scaffolds were investigated for their ability to support attachment, proliferation, and differentiation of human 
gastrointestinal epithelial and smooth muscle cell lines in order to ascertain their potential for tissue engineering. A 
bi-layer silk fibroin matrix composed of a porous silk fibroin foam annealed to a homogeneous silk fibroin film was 
evaluated in parallel with small intestinal submucosa scaffolds. AlamarBlue analysis revealed that silk fibroin scaffolds 
supported significantly higher levels of small intestinal smooth muscle cell, colon smooth muscle cell, and esophageal 
smooth muscle cell attachment in comparison to small intestinal submucosa. Following 7  days of culture, relative 
numbers of each smooth muscle cell population maintained on both scaffold groups were significantly elevated over 
respective 1-day levels—indicative of cell proliferation. Real-time reverse transcription polymerase chain reaction 
and immunohistochemical analyses demonstrated that both silk fibroin and small intestinal submucosa scaffolds were 
permissive for contractile differentiation of small intestinal smooth muscle cell, colon smooth muscle cell, esophageal 
smooth muscle cell as determined by significant upregulation of α-smooth muscle actin and SM22α messenger RNA 
and protein expression levels following transforming growth factor-β1 stimulation. AlamarBlue analysis demonstrated 
that both matrix groups supported similar degrees of attachment and proliferation of gastrointestinal epithelial 
cell lines including colonic T84 cells and esophageal epithelial cells. Following 14  days of culture on both matrices, 
spontaneous differentiation of T84 cells toward an enterocyte lineage was confirmed by expression of brush border 
enzymes, lactase, and maltase, as determined by real-time reverse transcription polymerase chain reaction and 
immunohistochemical analyses. In contrast to small intestinal submucosa scaffolds, silk fibroin scaffolds supported 
spontaneous differentiation of esophageal epithelial cells toward a suprabasal cell lineage as indicated by significant 
upregulation of cytokeratin 4 and cytokeratin 13 messenger RNA transcript levels. In addition, esophageal epithelial 
cells maintained on silk fibroin scaffolds also produced significantly higher involucrin messenger RNA transcript levels 
in comparison to small intestinal submucosa counterparts, indicating an increased propensity for superficial, squamous 
cell specification. Collectively, these data provide evidence for the potential of silk fibroin scaffolds for gastrointestinal 
tissue engineering applications.
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Introduction
The gastrointestinal (GI) tract is a continuous system of 
tubular organs, including the esophagus, stomach, small 
intestine, and colon, which is responsible for the transport 
and digestion of food, absorption of nutrients, and excre-
tion of waste. A wide spectrum of benign and malignant GI 
pathologies frequently requires surgical intervention to 
repair or replace damaged tissues in order to preserve ali-
mentary function. In patients afflicted with short bowel 
syndrome (SBS) wherein a reduction of more than 70% of 
normal jejunal–ileal length has occurred,1 intestinal 
lengthening procedures2 and allogeneic intestinal trans-
plantation3 have been deployed to increase functional 
absorptive capacity. However, major drawbacks with these 
approaches exist, including the continued reliance on total 
parenteral nutrition following intestinal elongation4,5 as 
well as immunojection risks in individuals receiving allo-
grafts.6,7 Long-gap esophageal defects resulting from 
esophageal atresia, strictures, and squamous cell carci-
noma are often repaired with gastric pull-up or interposi-
tion grafts using either jejunum or colon.8,9 Unfortunately, 
these methods are associated with substantial reductions in 
esophageal motility as well as donor site morbidity10,11 
which can severely impair patient quality of life.12,13 
Surgical colon resection is frequently utilized for manage-
ment of disorders of the large intestine such as Crohn’s and 
Hirschsprung’s diseases.14 However, increased stool fre-
quency and fecal incontinence represent undesirable con-
sequences of this mode of therapy.15,16 Given the limitations 
associated with conventional surgical approaches, there 
exists a substantial need for the development of alternative 
strategies for GI reconstruction.
Tissue engineering strategies deploying three-dimen-
sional (3D) biodegradable scaffolds either alone or seeded 
with primary or multi-potent cell sources have been inves-
tigated as implants for GI defect repair.17–19 Cell-free grafts 
composed of decellularized tissues such as small intestinal 
submucosa (SIS), acellular dermis, collagen-based sponges, 
and gastric acellular matrices have been shown to promote 
de novo epithelial and smooth muscle tissue formation in 
animal models of esophageal and small intestinal injury by 
supporting host tissue integration.18,20–22 However, deleteri-
ous side effects including graft contracture, implant perfo-
ration, obstruction, and stenosis are frequently observed,23–26 
thus raising concerns over the translational potential of 
these biomaterial configurations. Synthetic polyester-based 
matrices seeded with organoid units, multi-cellular clusters 
of epithelium, and mesenchyme harvested from neonatal or 
postnatal GI tissue have been reported to encourage tissue 
regeneration in defects of the esophagus,27 small intestine,28 
and colon.29 Unfortunately, degradation metabolites of pol-
yesters are known to elicit chronic inflammatory responses 
in vivo30 and therefore have the potential to negatively 
impact long-term organ function due to adverse foreign 
body reactions.31 In addition, the limited availability of 
human neonatal or postnatal donor tissue for organoid pro-
curement represents a practical barrier for widespread clini-
cal utilization of this technology.32
We hypothesize that the ideal strategy for GI tissue 
reconstruction would consist of an “off-the-shelf” acellu-
lar implant with the structural, mechanical, and degrada-
tive properties necessary to provide initial reinforcement 
to defect sites while allowing for gradual remodeling, host 
tissue ingrowth, and subsequent maturation of site-appro-
priate, functional tissue in the absence of adverse inflam-
matory reactions. Biomaterials derived from Bombyx mori 
silk fibroin (SF) represent attractive candidates for GI tis-
sue engineering due to their high structural strength and 
elasticity,33 diverse processing plasticity,34 tunable biodeg-
radability,35,36 and low immunogenicity.31,33 Previous stud-
ies from our laboratory have demonstrated the feasibility 
of bi-layer SF scaffolds to serve as acellular, biodegradable 
matrices for functional tissue regeneration of bladder37–39 
and urethral40 defects. The unique architecture of the bi-
layer SF scaffold configuration is also particularly suited 
for repair of GI perforations or replacement of diseased 
tissue sites since its porous compartment has the potential 
to promote ingrowth of surrounding host tissue while an 
SF film annealed to the porous layer is designed to provide 
a fluid-tight seal for retention of GI contents during defect 
consolidation.37,38 In the present study, we investigated the 
biocompatibility of this scaffold design for GI tissue engi-
neering by evaluating its ability to support attachment, 
proliferation, and differentiation of human GI epithelial 
and smooth muscle cell (SMC) lines in vitro. The ability of 
biomaterials to support these cellular processes is crucial 
for promoting host tissue integration and functional matu-
ration of regenerating tissue.
Materials and methods
Biomaterials
Bi-layer SF scaffolds were prepared using previously 
described procedures.37,40, 41 Briefly, cocoons from Bombyx 
mori were boiled for 20  min in an aqueous solution of 
0.02 M  Na2CO3, and rinsed with distilled water to elimi-
nate sericin and other contaminating proteins. Purified SF 
was solubilized in a 9  M LiBr solution and dialyzed 
(Pierce, Woburn, MA) against distilled water for 4  days 
with volume changes every 8 h. The resultant aqueous SF 
solution was diluted with distilled water to 6%–8% wt/vol 
and utilized for scaffold fabrication. The SF solution (8% 
wt/vol) was poured into a rectangular casting vessel and 
dried in a laminar flow hood at room temperature for 48 h 
to achieve formation of a SF film. A 6% wt/vol SF solution 
was then mixed with sieved granular NaCl (500–600 µM, 
average crystal size) in a ratio of 2 g NaCl per mL of SF 
solution and layered on to the surface of the SF film. The Franck et al.  3
resultant solution was allowed to cast and fuse to the SF 
film for 48 h at 37°C, and NaCl was subsequently removed 
by washing the scaffold for 72  h in distilled water with 
regular volume changes. The morphology of the bi-layer 
SF scaffold has been previously reported.37 Briefly, the 
solvent-cast/NaCl-leached layer comprised the bulk of the 
total matrix thickness (2 mm) and resembled a foam con-
figuration with large pores (pore size, ~400 µm) intercon-
nected by a network of smaller pores dispersed along their 
periphery. This compartment was buttressed on the exter-
nal face with a homogeneous, non-porous SF layer (200 µm 
thick) generated by film annealment during casting. Prior 
to in vitro experiments, bi-layer SF scaffolds were steri-
lized in 70% ethanol and rinsed in phosphate buffered 
saline (PBS) overnight. SIS matrices (Cook, Bloomington, 
IN) were evaluated in parallel as a standard point of com-
parison. Tensile properties of both scaffold configurations 
have been previously reported.37
GI SMCs
Primary SMC (passage 1) derived from human small intes-
tine SMC (siSMC), colon SMC (cSMC), and esophageal 
SMC (eSMC) (ScienCell Research Laboratories, Carlsbad, 
CA) were expanded for two additional passages on tissue 
culture plastic in SMC medium (SMCM, ScienCell) 
according to the manufacturer’s instructions. SMCM con-
sists of a bicarbonate buffered basal medium containing 2% 
fetal bovine serum (FBS), 1% of SMC growth supplement 
(SMCGS), and 1% of penicillin/streptomycin solution 
(P/S). For cell attachment and proliferation analyses, SMC 
lines (passage 4) were independently seeded on bi-layer SF 
and SIS matrices (106 cells/scaffold) in SMCM and cul-
tured statically in conical tubes for up to 7  days. Medium 
exchange was carried out every 3 days. To induce contrac-
tile differentiation, SMC lines were seeded on matrices as 
described above, serum depleted for 24  h in SMCM con-
taining 0.5% fetal calf serum (FCS), and subsequently 
exposed to 2.5 ng/mL transforming growth factor-β1 (TGF-
β1) (R&D Systems, Minneapolis, MN) for 24  h. Control 
cultures were maintained in parallel in SMCM for 3 days.
GI epithelial cells
The human T84 epithelial cell line derived from colonic 
adenocarcinoma (American Type Culture Collection 
(ATCC), Manassas, VA) was expanded to passage 56 on 
tissue culture plastic in complete growth medium consist-
ing of a 1:1 mixture of Ham’s F12 medium and Dulbecco’s 
modified Eagle’s medium (DMEM), 2.5 mM L-glutamine, 
15  mM hydroxyethyl piperazine ethanesulfonic acid 
(HEPES), 0.5  mM sodium pyruvate, and 1200  mg/L 
sodium bicarbonate (DMEM:F-12, ATCC), supplemented 
with 5% FBS (Life Technologies, Grand Island, NY). 
Human primary esophageal epithelial (eEP) cells (passage 
1) (ScienCell) were expanded for three additional passages 
on tissue culture plastic in Epithelial Cell Medium-2 
(EpiCM-2, ScienCell) according to the manufacturer’s 
instructions. EpiCM-2 consists of 1% of epithelial cell 
growth supplement-2 (EpiCGS-2) and 1% of P/S. eEP and 
T84 cells were independently seeded on bi-layer SF and 
SIS matrices (106 cells/scaffold) and cultured statically in 
conical tubes in respective growth media for up to 7 or 
14  days to assess cell attachment, extent of proliferation, 
and differentiation status. Medium exchange was per-
formed every 3 days.
Cell attachment and proliferation analyses
The relative number of metabolically active cells follow-
ing 24 h of cell seeding and over the course of cultivation 
on each matrix group was determined by the alamarBlue 
assay (Life Technologies) according to the manufacturer’s 
instructions. Briefly, scaffolds seeded with cell lines were 
incubated in their respective culture medium supplemented 
with 10% alamarBlue reagent for 2  h at 37°C with 5% 
CO2. Post reaction medium aliquots (100 µL) were trans-
ferred to 96-well plates and quantified for fluorescence 
intensity within a FLUOstar Omega plate reader (BMG 
Labtech Inc., Durham, NC) using an excitation wavelength 
of 560  nm and an emission wavelength of 590  nm. Non-
seeded matrices were screened in parallel as background 
controls. Relative cell numbers were calculated as the 
degree of relative fluorescence units (FU) per construct as 
previously described.42
Messenger RNA analysis
Total RNA was extracted from cell seeded scaffolds accord-
ing to the single step acid-phenol guanidinium method43 
using Trizol reagent (Life Technologies). Messenger RNA 
(mRNA) was enriched from total RNA using the RNeasy 
kit (Qiagen Inc., Valencia, CA), and complementary DNAs 
(cDNAs) were synthesized using the High-Capacity cDNA 
Transcription kit (Applied Biosystems, Foster City, CA) 
following the manufacturer’s instructions. Real-time 
reverse transcription polymerase chain reaction (RT-PCR) 
reactions were performed and analyzed using the Applied 
Biosystems StepOnePlus™ Real-time PCR Detection 
System and StepOne Software (version 2.1). cDNA sam-
ples were assessed for genes of interest and the housekeep-
ing gene, GAPDH, in independent reactions using the 
Taqman Universal PCR master mix in combination with 
commercially available primers and probes consisting of 
Assays-on-Demand™ Gene Expression kits (Applied 
Biosystems) following the manufacturer’s instructions. 
Expression kits included α-smooth muscle actin (SMA), 
Hs00426835_g1; SM22α, Hs00162558_m1; lactase, 
Hs00158722_m1; maltase, Hs01090216_m1; cytokeratin 
(CK) 4, Hs00361611_m1; CK13, Hs00357961_g1; 4  Journal of Tissue Engineering   
involucrin, Hs00846307_s1; GAPDH, Hs02758991_g1. 
For each cDNA sample, the threshold cycle (Ct) was 
defined as the cycle number at which amplification of the 
target gene was within the linear range of the reaction. 
Relative expression levels for each gene of interest were 
calculated by normalizing the target gene transcript level 
(Ct) to the respective GAPDH level with the maximum 
expression values per gene displayed at a 100 per condition 
as described previously.42
Histological, immunohistochemical, and 
scanning electron microscopy analyses
Cell-seeded constructs were fixed in 10% neutral-buffered 
formalin, dehydrated in graded alcohols, and then embed-
ded in paraffin. Sections (5 µm) were cut and then stained 
with hematoxylin and eosin (H&E) using routine histo-
logical protocols. For immunohistochemical (IHC) analy-
ses, contractile smooth muscle markers such as α-SMA 
and SM22α and intestinal epithelial markers including 
brush border enzymes, lactase, and maltase were detected 
using the following primary antibodies: anti-α-SMA 
(Sigma-Aldrich, St. Louis, MO; 1:200 dilution), anti-
SM22α (Abcam, Cambridge, MA; 1:200 dilution), anti-
lactase (Abcam; 1:200 dilution), and anti-maltase (Santa 
Cruz Biotechnology, Dallas, TX; 1:200 dilution). Sections 
were then incubated with species-matched Cy3-conjugated 
secondary antibodies (EMD Millipore, Billerica, MA) and 
nuclei were counterstained with 4′,6-diamidino-2-phenyl-
lindole (DAPI). Specimens were visualized using an 
Axioplan-2 microscope (Carl Zeiss MicroImaging, 
Thornwood, NY), and representative images were acquired 
using Axiovision software (version 4.8). In some cases, 
cell distribution in seeded constructs was determined by 
scanning electron microscopy (SEM) using previously 
published procedures.44
Statistical analyses
All quantitative measurements were collected with N = 3–4 
independent replicates per data point from one representa-
tive experiment and expressed as mean ± standard deviation. 
Data for these measurements were analyzed with the Mann–
Whitney U test for independent samples and the Wilcoxon 
signed-rank test for paired samples using SPSS Statistics 
software v19.0 (http://www.spss.com). Statistically signifi-
cant values were defined as p < 0.05.
Results and discussion
Bi-layer SF and SIS matrices were assessed for their ability 
to mediate attachment and proliferation of GI SMC lines 
(Figure 1). Following 24  h of cell seeding, alamarBlue 
analysis demonstrated that bi-layer SF scaffolds supported 
significantly higher levels of attachment for all SMC lines 
examined in comparison to SIS matrices. At the 7-day 
timepoint, relative numbers of each SMC population main-
tained on both bi-layer SF and SIS scaffolds were signifi-
cantly elevated over their respective 1-day levels—indicative 
of cell proliferation. Parallel histological evaluations 
(hematoxylin and eosin (H&E) analysis) at 7 days revealed 
that each SMC line displayed a spindle-shaped morphology 
and was organized into multi-cellular layers primarily dis-
persed along the periphery of both biomaterial surfaces. 
Overall, these data show that bi-layer SF matrices are capa-
ble of promoting GI SMC attachment and proliferation.
Phenotypic modulation of SMC from a proliferative, 
synthetic state into a quiescent, contractile phenotype is a 
dynamic, reversible process which plays key roles in tissue 
homeostasis and response to injury throughout hollow 
organs.45 In order for biomaterial grafts to reconstitute the 
contractile properties of tissue defects and support peri-
stalsis of the digestive tract, they must serve as permissive 
substrates for contractile differentiation of synthetic SMC. 
Following tissue isolation and ex vivo expansion, primary 
SMC populations are known to dedifferentiate from a con-
tractile to a synthetic phenotype.46–47 Serum deprivation in 
combination with TGF-β1 treatment has been reported to 
induce re-acquisition of contractile markers in ex vivo 
expanded, synthetic SMC derived from vascular48 and uro-
genital tissues.42,46 Therefore, we investigated the potential 
of these differentiation stimuli to elicit similar responses in 
GI SMC lines cultured on bi-layer SF and SIS matrices 
(Figure 2). Real-time RT-PCR analysis demonstrated that 
following TGF-β1 treatment, each SMC type cultured on 
both scaffold groups significantly upregulated α-SMA and 
SM22α mRNA transcript levels over respective control 
values. In addition, IHC evaluations revealed that all TGF-
β1-treated constructs displayed prominent degrees of α-
SMA and SM22α protein expression with qualitatively 
similar levels of positive staining observed across all cell 
types and matrix configurations examined. In contrast, 
non-stimulated control groups displayed qualitatively 
weak and sparse expression of both markers by compari-
son (data not shown). These results demonstrate that bi-
layer SF matrices are efficacious in supporting contractile 
differentiation of GI SMC lines.
The diverse epithelia of the GI tract serve a number of 
critical functions such as enzyme secretion, nutrient 
absorption, as well as participation in innate and adaptive 
immune responses.49 The ability of tissue-engineered 
constructs to reconstitute the epithelium of GI tissue 
defects depends on the potential of scaffold configura-
tions to promote host epithelial ingrowth and differentia-
tion. Bi-layer SF and SIS matrices were first evaluated 
for their capacity to support attachment and proliferation 
of two GI epithelial cell lines: T84 and eEP (Figure 3). 
AlamarBlue analysis revealed that following initial cell 
seeding, both scaffold groups displayed similar levels of 
relative cell attachment for each cell line studied. Franck et al.  5
Following 14 days of culture, significant increases in rel-
ative cell numbers were observed in both T84-seeded 
biomaterials over respective 1-day levels, and histologi-
cal evaluations (H&E analysis) demonstrated the forma-
tion of polarized cell layers lining the perimeter of each 
scaffold configuration. In addition, relative cell numbers 
of eEP cells on both bi-layer SF and SIS matrices at 
7 days of culture were also found to significantly increase 
with respect to 1-day values. However, in contrast to T84 
cells, SEM analysis demonstrated that eEP cells were 
localized in disperse patches along each scaffold surface 
and did not form detectable cohesive cell layers as 
observed on other biomaterial substrates.50 Our previous 
results have shown the ability of extracellular matrix 
coatings such as fibronectin to enhance urologic epithe-
lial interactions to SF biomaterials.42 This strategy may 
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Figure 1.  Attachment and proliferation of GI SMC lines on scaffold groups. (a–c) AlamarBlue analysis of the extent of relative cell 
attachment and proliferation for each SMC line cultured independently on bi-layer SF and SIS matrices over the course of 7 days. 
FU = Fluorescence units, mean ± SD per data point. #p < 0.05, in comparison to levels observed on SIS constructs at 1 day of culture. 
*p < 0.05, in comparison to respective levels observed on SIS and bi-layer SF constructs at 1 day of culture. (a′–c′) Photomicrographs 
of SMC-seeded constructs (H&E-stained sections) following 7 days of culture as described in respective (a–c) counterparts. Scale 
bars = 200 µm. SC denotes scaffolds.
GI: gastrointestinal; SMC: smooth muscle cell; SF: silk fibroin; SIS: small intestinal submucosa; SD: standard deviation; H&E: hematoxylin and eosin.6  Journal of Tissue Engineering   
represent a useful approach in order to improve construct 
cellularity in the current system.
T84 and eEP cell lines have been demonstrated to 
undergo spontaneous differentiation upon confluency in 
various two-dimensional (2D) and 3D cell culture mod-
els.50–53 T84 cells acquire features of small intestinal entero-
cytes including expression of the brush border enzymes 
such as lactase and maltase;51,52 while proliferating, 
CK5 + CK14 + basal eEP cells mature into a suprabasal cell 
lineage  expressing  CK4 + CK13 + a  superficial,  squamous 
cell phenotype which produces involucrin.50,53 The bi-layer 
SF and SIS scaffolds were assessed for their ability to sup-
port spontaneous differentiation of T84 and eEP cell lines 
(Figure 4). Real-time RT-PCR analysis demonstrated that 
T84 cells cultured on both scaffold groups significantly 
increased mRNA transcript levels of lactase and maltase at 
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Figure 2.  Contractile differentiation of GI SMC lines on matrix groups. (a–c) Real-time RT-PCR analyses of mRNA transcript 
levels of contractile markers (α-SMA and SM22α) in synthetic (SYN) and TGF-β1-treated constructs seeded with SMC lines. Levels 
normalized to GAPDH expression. Mean ± SD per data point. For each marker, *p < 0.05, in comparison to levels in respective 
SYN controls. (a′–c′) Photomicrographs of contractile protein expression in TGF-β1-treated constructs as described in respective 
(a–c) counterparts. Immunofluorescence of contractile proteins (Cy3 fluorophore, red). DAPI nuclear counterstain (blue). Scale 
bars = 100 µm.
GI: gastrointestinal; SMC: smooth muscle cell; RT-PCR: reverse transcription polymerase chain reaction; mRNA: messenger RNA; SMA: smooth 
muscle actin; TGF-β1: transforming growth factor-β1; SD: standard deviation; DAPI: 4′,6-diamidino-2-phenyllindole.Franck et al.  7
14  days with respect to 1-day levels. In addition, IHC 
assessments revealed that T84 cells cultured on each matrix 
configuration for 14  days displayed qualitatively similar 
levels of lactase and maltase protein expression. These data 
show the ability of bi-layer SF scaffolds to support entero-
cytic differentiation of T84 cells to a comparable degree 
as SIS.
In contrast to the results obtained with T84 cells, dis-
tinct differences were observed in the capacity of the 
biomaterial groups to promote eEP differentiation. 
Following 7  days of culture on bi-layer SF scaffolds, 
real-time RT-PCR analysis demonstrated that eEP cells 
significantly upregulated CK4 and CK13 mRNA tran-
script levels over 1-day values, indicative of suprabasal 
cell specification. However, these markers declined 
from 1-day baseline levels when eEP cells were cultured 
on SIS matrices. Evidence for superficial, squamous eEP 
differentiation was detected in both scaffold groups by 
the presence of involucrin expression; however, bi-layer 
SF constructs supported significantly higher mRNA 
transcript levels (2.4-fold) at 7  days of culture in com-
parison to SIS matrices. Bioactive growth factors in SIS 
scaffolds such as TGF-β154 have the potential to exert 
inhibitory roles in eEP cell differentiation processes,55 
and therefore, their presence may account for the 
observed differences between the two matrix configura-
tions. Indeed, previous studies have reported incomplete 
epithelialization of SIS grafts in in vivo models of 
esophageal repair.56,57
Conclusion
The results presented in this study detail the ability of bi-
layer SF scaffolds to support attachment, proliferation, and 
differentiation of human GI epithelial and SMC lines in 
vitro. In comparison to conventional SIS matrices, bi-layer 
SF scaffolds promoted increased extents of attachment for 
each SMC line examined as well as a greater propensity 
for eEP cell differentiation toward suprabasal and superfi-
cial phenotypes. Future in vivo evaluations in models of 
defect repair are necessary to determine the potential of 
these scaffolds for GI organ reconstruction. In summary, 
bi-layer SF scaffolds represent promising platforms for GI 
tissue engineering.
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Figure 3.  Attachment and proliferation of GI epithelial cell lines on scaffold groups. (a and b) AlamarBlue analysis of the extent of 
relative cell attachment and proliferation for each epithelial cell line cultured independently on bi-layer SF and SIS matrices over the 
course of 7 or 14 days. FU = Fluorescence units, mean ± SD per data point. *p < 0.05, in comparison to respective levels observed 
on SIS and bi-layer SF constructs at 1 day of culture. (a′ and b′) Photomicrographs of epithelial cell lines cultured on each scaffold 
group for 7 or 14 days (H&E-stained sections, T84 and SEM, eEP). For a′, scale bar = 200 µm. SC denotes scaffolds. For b′, scale 
bar = 30 µm.
GI: gastrointestinal; SF: silk fibroin; SIS: small intestinal submucosa; SD: standard deviation; H&E: hematoxylin and eosin; SEM: scanning electron 
microscopy; eEP: esophageal epithelial.8  Journal of Tissue Engineering   
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